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Objectives: To determine if Duplex ultrasound (DUS) 1 dayafter percutaneous transluminal angioplasty (PTA) is 
prognostic for haemodynamic and clinical results at 1 year. 
Design: Prospective study. 
Patients and methods: Thirty-four femoropopliteaI artery segments were treated with PTA. The peak systolic velocity 
ratio (PSV ratio = PSV in stenosis: PSV in normal segment) wasdetermined with DUS before PTA, 1 day after PTA and 
1 year after PTA. Clinical results were assessed with the SVS/ISCVS (Society for Vascular Surgery~International Society 
for CardioVascular Surgery) results classification. 
Results: A 1 year, clinical benefit from PTA was seen in 16 of 25 patients (64%) and haemodynamic improvement in 20 
of 34 treated segments (59%). With DUS three residual stenoses were found 1 day after PTA; all occluded within 1 year. 
Segments with good DUS results after PTAshowed haemodynamic deterioration in 30%. Clinical improvement was seen 
in most patients with DUS improvement, whereas no change or deterioration was found in patients with both good and 
poor DUS results at 1 year. 
Conclusions: Residual stenosis on DUS 1 day after PTA is prognostic for failure within 1 year. However, good DUS 
results after PTA cannot predict haemodynamic success. Haemodynamic success at 1 year does not imply clinical 
success.  
Key Words: Femoropopliteal artery; Stenosis; Angioplasty; Duplex ultrasound. 
Introduction 
Duplex ultrasound (DUS) can be used as a non- 
invasive examination to localise and grade the sever- 
ity of peripheral arterial disease and to study the 
natural history of femoropopliteal rtery stenoses. 1 
Follow-up studies after endovascular p ocedures can 
be easily performed. 2-4 Immediate results of Percuta- 
neous transluminal angioplasty (PTA) as seen on 
angiography are sometimes difficult to analyse 
because of dissections at the PTA site which obscure 
the true lumen diameter. DUS uses velocity criteria to 
grade stenoses. If dissections are present in the vessel 
lumen, the peak systolic velocity (PSV) could be 
influenced because of intramural thrombus formation 
and dissections which decrease the lumen diameter. 
DUS shortly after PTA showed contradictory esults in 
the literature. 2--5 The question remains whether DUS 
*Please address all correspondence to: Anje M. Spijkerboer, Depart- 
ment of Radiolog~ Twenteborg Ziekenhuis, Postbus 7600, 7600 SZ 
Almelo, The Netherlands. 
after PTA can predict the outcome of PTA. 5 We 
undertook a prospective study to see whether DUS 
one day after PTA is prognostic for haemodynamic 
and clinical results at 1 year after PTA. 
Patients and Methods 
Twenty-nine patients were entered in the study. A 
technical failure occurred in one case, in which the 
guide wire could not cross the stenosis. This patient 
was excluded from the follow-up study. Two patients 
died within a year after PTA and one patient was lost 
during the follow-up period. Finally, 25 patients with 
34 lesions (31 stenoses and 3 occlusions) were treated 
with PTA and evaluated with DUS. Lesion character- 
istics, including the treated segment and the length of 
the stenosis, are shown in Table 1. The mean age was 
62.6 years (range 39-79 years), with 10 females (mean 
age 67.3 years, range 52,-79 years) and 15 males (mean 
age 59.5 years, range 39-75 years). 
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Table 1. Lesion characteristics (34 lesions). 
(a) Treated segment 
Common femoral rtery 3 
Superficial femoral rtery 30 
Popliteal rtery 1 
Total 34 
(b) Length of stenosis/occlusion 
Short (1-2 cm) 30 
Long (5-10 cm) 4 
The indication for PTA was lifestyle-limiting claudi- 
cation or ischaemic rest pain. According to the clinical 
categories of chronic limb ischaemia (as described by 
Rutherford et al. 6) 12 patients (17 lesions) were listed 
in category 1 (mild claudication), nine patients (13 
lesions) in category 2 (moderate claudication), three 
patients (three lesions) in category 3 (severe claudica- 
tion) and one patient (one lesion) in category 4 
(ischaemic rest pain). Risk factors were hypertension 
in nine patients, diabetes mellitus in six patients and 
smoking in 15 patients. 
The patients received 100 mg of aspirin 1 day prior 
to the PTA, which was continued for at least 3 months. 
If the patient was on anticoagulation therap~ no 
aspirin was given and the anticoagulation therapy 
was continued. During the procedure 5000 IU of 
heparin were given intra-arterially and nitroglycerin f 
deemed necessary. PTA was performed according to 
standard methods. A 6 or 7 F sheath was used in all 
procedures. In most procedures an antegrade punc- 
ture technique was used (17 patients). Five retrograde 
puncture techniques and three popliteal puncture 
techniques were used. The diameter of the balloon 
was chosen by measuring the proximal or distal 
normal arterial lumen on the angiogram. The balloon 
was inflated with a manometer to a maximum of 12 
atmospheres for 30s, and this was repeated twice. 
Control angiograms at the end of the procedure were 
usually performed in unilateral planes. 
PTA was considered successful if the angiogram 
showed a less than 30% residual stenosis. A residual 
stenosis was defined when angiographically a more 
than 30% lumen diameter eduction was present 
despite multiple balloon inflations. 
DUS studies were performed with either an ATL 
Ultramark 8 or 9 machine (Advanced Technology 
Laboratories, Bothell, WA, U.S.A.). A linear array 
(5 MHz or 5-10 MHz) transducer probe was used. The 
Ultramark 9 machine was equipped with colour 
Doppler. A rule was placed on the upper leg using the 
patella s a landmark. This allowed localisation of the 
PTA site in the follow-up period so that measurements 
at the PTA site could be compared. The femoral artery 
was first visualised, then the PSV was measured in 
every segment of the common femoral arter~ the 
superficial femoral artery and the popliteal artery. The 
PSV was  determined from the Doppler spectrum, 
acquired by positioning the Doppler sampling gate 
centre-stream in the flow after Doppler angle correc- 
tion with a maximum of 60 °. The PSV ratio was 
obtained by dividing the PSV in the stenosis by the 
PSV in a normal appearing segment proximal to the 
stenosis, or in case of an original stenosis distal from 
the stenosis. A PSV ratio >_2.5 was considered to 
represent a haemodynamically significant stenosis as 
has been documented in the literature. 7-9 
DUS was performed within a week before PTA, 1 
day after PTA, and 1 year after PTA. When a patient 
underwent bypass surgery within a year after PTA, 
then the preoperative ankle-brachial index (ABI), 
walking distance and ankle pressures were used to 
define the clinical result. 
With DUS we defined a good result after PTA when 
the PSV ratio was < 2.5 1 day post-PTA and < 2.5 1 
year post-PTA. A recurrent stenosis was considered to 
be present when the PSV ratio was < 2.5 1 day post- 
PTA, but >_2.5 at 1 year. A residual stenosis was 
defined when the PSV ratio was >_ 2.5 1 day and I year 
post-PTA. When a segment was occluded at the time 
of the DUS examination, o ratio could be determined. 
In this case the ratio was considered as being >_ 2.5. 
The clinical results were assessed with results 
classification according to the Society for Vascular 
Surgery/International Society for CardioVascular Sur- 
gery (SVS/ISCVS) which incorporates the walking 
distance, ABI and 6 ankle pressures. Clinical results 
improved when a + 1, + 2 or + 3 result was obtained. 
No change or deterioration of the clinical situation 
was accorded to a 0, -1, -2 and -3 result. Associations 
were tested with the Fisher exact est and expressed as 
relative risks with 95% confidence intervals (95% 
C.L). 
Results 
The initial angiographic results after PTA of 34 lesions 
in 25 patients howed 23 lesions with good results. 
Eleven lesions showed a moderate result with a 
residual stenosis of 30-50% lumen diameter reduction 
after PTA. Additional treatment was not performed in 
these 11 lesions since an increase of the vessel 
diameter was achieved with angioplasty and multiple 
balloon inflations could not improve the final result. 
Dissections at the PTA site were present in 20 lesions 
(59%). 
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Table 2. Duplex ultrasound results after percutaneous transluminal 
angioplasty. 
One day post-PTA One year post-PTA 
No. segments (PSV ratio) (PSV ratio) 
~a2.5 :  3* Residual stenosis 
34 / />2.5 :3  <2.5:0 
~<2.5 :31  - >2.5: 11"* 
~- -~ <2.5:20 
Recurrent stenosis 
Good result 
PTA=Percutaneous transluminal angioplasty; PSV=Peak systolic 
velocity. 
*Three occlusions. 
**Six occlusions and five stenoses. 
In Table 2 the DUS results after PTA are shown. The 
mean PSV ratio before PTA was 4.4 (range 1.8-10.0). 
One day after PTA the mean PSV ratio was decreased 
to 1.8 (range 1.0-3.8). At 1 year the mean ratio 
increased to 2.0 (range 1.0-4.0). DUS showed improve- 
ment in all lesions 1 day after PTA compared to pre- 
PTA values. However, three lesions howed a residual 
stenoses with a PSV ratio _> 2.5. These three segments 
occluded within I year after PTA. At 1 year 20 lesions 
(58.8%) showed good DUS results, nine lesions 
(26.5%) were occluded and five lesions (14.7%) 
showed a significant stenosis. The three short occlu- 
sions treated with PTA showed good DUS results at 1 
year. Of 31 segments with a good response after PTA 
(PSV ratio < 2.5) 11 segments deteriorated haemody- 
namically (recurrent stenoses), of which six segments 
occluded. 
Table 3 compares the angiographic results and the 
DUS results 1 day and I year after PTA and the clinical 
results at 1 year. Nine of the 11 lesions with angio- 
graphically residual stenoses showed good DUS 
results 1 day after PTA. Of the 11 angiographically 
residual stenoses in eight patients, four lesions 
showed good DUS results at 1 year and four patients 
showed clinical improvement a I year. Eighty percent 
of the lesions with good DUS results at I year showed 
initially good angiographic results. 
In Fig. 1 a scatter plot is given in which DUS results 
at 1 day are compared to DUS results at 1 year. The 
Table 3. Angiographic results compared to DUS results 1 day and 
patients). 
occluded lesions are positioned on top with imaginary 
PSV ratios of 5.0. In Table 4 the DUS results i day after 
PTA are compared to the haemodynamic and clinical 
results at 1 year. Eleven lesions (35.5%) with initially 
good DUS results showed recurrence of stenosis. Of 
patients with initially good DUS results, 30% did not 
show clinical improvement a i year. The two patients 
with the three residual stenosis 1 day after PTA did 
not show clinical improvement a 1 year. Poor DUS 
results 1 day after PTA predicted haemodynamic 
failure at 1 year (RR = 2.8 with 95% C.I. 1.8-4.5, 
p = 0.06). When a residual stenosis is found with DUS 
1 day after PTA this lesion is 2.8 times more likely to 
show a significant stenosis at 1 year than the lesions 
which have good DUS results 1 day after PTA. 
Clinical success in terms of a + 1, + 2 or + 3 result 
(clinical improvement) was found in 16 patients 
(Tables 3-5) Nine patients did not change or deterio- 
rated clinically within 1 year after PTA compared to 
the situation before PTA. The two patients with three 
residual stenoses (DUS) after PTA deteriorated. The 
relative risk of a patient with a residual stenosis after 
PTA to show no clinical success is slightly, but not 
significantly, elevated. These data must be interpreted 
with caution because of the small number of 
patients. 
The DUS results at 1 year compared to clinical 
results at 1 year are shown in Table 5. In 19 patients 
agreement was found between DUS results and 
clinical results. However in six patients (24%) dis- 
agreement was found. Three patients howed clinical 
improvement although DUS indicated a residual 
stenosis at the PTA site. Three patients howed no 
improvement clinically but DUS results were good. 
According to the DUS results, at 1 year 41% of 34 
segments had significant stenoses or occlusions. 
According to the clinical results, 64% of 25 patients 
showed benefit from the procedure at 1 year, 36% 
showed no change or deterioration. Good DUS results 
at 1 year in combination with clinical improvement 
was found in 13 of 25 patients (52%) (Table 5). Poor 
DUS results at 1 year in combination with no clinical 
year post-PTA (n=34 segments) and clinical results at 1 year (n=25 
Angiographic results 
Good (23) 
Moderate (11) 
Total 
DUS results DUS results Clinical results 
I day I year 1 year 
Good Residual Good Recurrent Residual Impr. No impr. 
22 1 16 6 1 12 5 
9 2 4 5 2 4 4 
31 3 20 11 3 16 9 
PTA=Percutaneous transluminal angioplasty; DUS= Duplex ultrasound; impr.= improvement. 
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Fig. 1. DUS 1 day and 1 year after PTA (n = 34). 
change or deterioration was found in six of 25 patients 
(24%). This gives agreement between DUS results and 
clinical results at one year of 76% (in 19 of 25 
patients). 
Discussion 
Immediate success after PTA of femoropopliteal artery 
stenoses i  usually determined by the morphological 
aspect at the PTA site is shown by angiography. 
Dissections and plaque fractures are commonly found 
410 as a result of the procedure. ' Follow-up with non- 
invasive tests like ABI measurements and pulse 
volume recordings i  still used to determine patency, 
11 12 but are not reliable in showing residual stenoses. ' 
DUS was used by Mewissen et al. and Sacks et al. to 
predict outcome after PTA or femoropopliteal rtery 
stenosis. 2~4 However, the authors report conflicting 
results as shown by Yucel. s Sacks et al.'s first article 
showed that DUS after PTA is not useful to predict 
subacute restenosis. They found high PSV ratios at the 
PTA site which did not correlate with residual 
stenoses as determined by angiographic, haemody- 
namical, or clinical criteria. 2 Mewissen et al. and 
Kinney et al., on the other hand, described that DUS 
post-PTA is predictive of clinical deterioration and 
PTA failure. 4'13 We found similar results to Mewissen 
et al. If 2.5 is chosen as a ratio of haemodynamic 
significance, there were three residual stenoses after 
PTA, and all three lesions occluded within 1 year. In 
these three cases DUS 1 day after PTA was prognostic 
Table 4. DUS results I day after PTA compared to haemodynamic and clinical outcome at I year. 
DUS results 1 day 
No stenosis 
Stenosis 
Total 
DUS results i year 
(n=34 segments) 
Clinical results 1 year 
(n=25 patients) 
No stenosis Stenosis / occl. Impr. No impr. 
20 11 16 7 
0 3 0 2 
20 14 16 9 
RR=2.8 (95% C.I. 1.8-4.5), p=0.06 RR=4.1 (95% C.I. 0.3-52.5), p=0.12 
PTA=Percutaneous transluminal angioplasty; DUS=Duplex ultrasound; occl.=occlusion; impr.=improvement; RR=relative risk; 
C.I.=confidence interval. 
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Table 5. DUS results 1 year post-PTA compared to clinical results 
at I year (n=25 patients). 
DUS results i year 
No stenosis 
Stenosis occl. 
Clinical results I year 
Impr. No impr. 
16 
9 
25 
13 3 
3 6 
16 9 
RR-=I.9 (95% C.I. 0.8--4.6), p=0.07 
DUS=Duplex ultrasound; PTA=Percutaneous 
angioplasty; occl.=occlusion; RR=relative risk; 
interval; impr.=improvement. 
transluminal 
C.I. =confidence 
for haemodynamic and clinical failure. DUS per- 
formed 1 day after PTA is therefore helpful in 
detecting residual stenoses which will need secondary 
treatment. 
Eleven lesions with good DUS results 1 day after 
PTA showed a recurrent stenosis 1 year after PTA. 
These recurrent stenoses probably develop because of 
intimal hyperplasia t the PTA site. DUS post-PTA 
could not predict hat these recurrent stenoses would 
develop within 1 year. The initial angiographic result 
of recurrent stenoses was equally divided between a
good result and a moderate result (Table 3). The 
patients with recurrent stenoses that occluded showed 
worse clinical results than patients with recurrent non- 
occluded stenoses. 
DUS criteria are differently used in the literature for 
quantification of a significant stenosis. Sacks, Mewis- 
sen et al.'used PSV ratios > 2.0. 3'4'13 Sacks et al. also 
used a PSV > 120cm/s to define stenoses >50%. In 
our hospffal PSV ratios _>2.5 are used to define 
significant stenoses with a > 50% diameter eduction 
as described by Legemate t al. 7'9 Ranke et al. proposed 
a ratio of 2.4 as best criterion for a significant stenosis. 8 
When DUS criteria as used by Sacks et al. and 
Mewissen et al. were used in our study (PSV ratio 
2.0), we could have found 13 residual stenoses i day 
after PTA. However, these 13 PTA sites showed good 
angiographic results after PTA in eight lesions. We 
believe that a PSV ratio of 2.0 is not specific enough to 
detect significant stenoses. Too many stenoses in the 
femoropopliteal rtery would be found without clin- 
ical significance. DUS results were assessed before and 
after PTA, showing improvement in all PTA sites, a 
similar finding as shown by Sacks et al. 3 
The initial angiographic appearance after PTA 
showed a moderate result (30-50% residual stenosis) 
in 11 PTA sites. We did not define these procedures as 
technically unsuccessful, since increase of the vessel 
diameter was found after angioplasty in these lesions. 
However, of these 11 segments (eight patients) with a 
moderate result, four segments (36%) showed good 
DUS results at 1 year and four patients (50%) showed 
clinical improvement I year after PTA (Table 3). From 
these data we can conclude that postangioplasty 
angiographic appearance does not correlate well with 
DUS results post-PTA as reported in the literature. 4 
The initial angiographic result is not predictive of PTA 
outcome at 1 year, since lesions with good results 
angiographically showed recurrent stenoses and 
occlusions at I year, and lesions with moderate results 
angiographically showed variable outcome. This is in 
contradiction with results described by E1-Bayar. 14 He 
reported that the technical appearance of the post- 
angioplasty arteriogram impacts on the success of the 
procedure in the short-term and long-term periods. 
Miller et al. reported that the length of the treated 
stenosis was important for long-term outcome. 15 We 
treated four long lesions ( > 4 cm) and 30 short lesions 
(1-2 cm)(Table lb). Three of the four long lesions were 
successfully treated with both haemodynamical nd 
clinical improvement at 1 year. This small amount of 
treated long stenoses will make conclusions on this 
subject impossible, although Miller et al. reported 
better long-term results with short lesions. 
A limitation of our study is the relative small 
amount of patients and PTA sites. Nevertheless, in all 
25 patients prospectively DUS examinations were 
performed before PTA, 1 day after PTA and 1 year 
after PTA, and in all patients clinical results were 
assessed with the recently propagated categories and 
results classification, according to the SVS/ISCVS. 6 
Our patient group is homogeneous since only patients 
with femoropoliteal lesions were compared, whereas 
Sacks et aI. investigated and compared results of both 
iliac and femoropoliteal lesions.2'3A second limitation 
is that in some femoropopliteal rteries more than one 
lesion was treated. The clinical outcome will be the 
same for these tandem lesions, but DUS results will be 
different. The PTA site with the worst haemodynamic 
result will influence the clinical outcome in that 
patient. 
A Duplex surveillance programme for treatment 
femoropopliteal rteries, which is also recommended 
for vein grafts, will show its benefit as can be 
concluded from this article, is Lesions which deterio- 
rate, can be monitored and significant recurrent 
stenoses can be detected and treated, sustaining 
secondary patency. 
In conclusion, poor DUS results 1 day after PTA of 
femoropopliteal rtery stenoses is prognostic for hae- 
modynamic and clinical failure within i year. Patients 
with poor DUS results poor PTA will need secondary 
treatment o obtain vessel patency. However, good 
DUS results after PTA cannot predict haemodynamic 
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or clinical success at I year, because of development of 
recurrent stenoses and progression of atherosclerotic 
disease at other sites. 
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